Achieve Life Sciences (ACHV) Misses Q4 EPS by 2c

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.36), $0.02 worse than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Venu Holding enters $250 million at-the-market stock offering agreement
• PreveCeutical closes second tranche of private placement for $245,000